Insider · CIK 0001379970
GILMAN STEVEN C
Reports to the SEC for 7 companies · LEXINGTON, MA
Transactions
50
Companies
7
Filings
8
CIK
0001379970
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-06-26 | SCYXSCYNEXIS INC · Stock OptionA Award | — |
| 2025-06-26 | SCYXSCYNEXIS INCA Award | — |
| 2025-06-10 | AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award | — |
| 2025-06-10 | AKBAAkebia Therapeutics, Inc.A Award | — |
| 2024-10-16 | VCELVericel CorpM Exercise/Conversion | +$76.1K |
| 2024-10-16 | VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-10-16 | VCELVericel CorpS Sale | −$241K |
| 2024-10-02 | VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-10-02 | VCELVericel CorpM Exercise/Conversion | +$76.1K |
| 2024-10-02 | VCELVericel CorpS Sale | −$235K |
| 2024-09-18 | VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-09-18 | VCELVericel CorpM Exercise/Conversion | +$76.1K |
| 2024-09-18 | VCELVericel CorpS Sale | −$266K |
| 2024-09-04 | VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-09-04 | VCELVericel CorpM Exercise/Conversion | +$18.7K |
| 2024-09-04 | VCELVericel CorpS Sale | −$243K |
| 2024-06-20 | SCYXSCYNEXIS INC · Stock OptionA Award | — |
| 2024-06-20 | SCYXSCYNEXIS INCA Award | — |
| 2024-06-06 | AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award | — |
| 2024-06-06 | AKBAAkebia Therapeutics, Inc.A Award | — |
| 2024-05-01 | VCELVericel CorpM Exercise/Conversion | — |
| 2024-05-01 | VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion | — |
| 2024-05-01 | VCELVericel Corp · Restricted Stock UnitA Award | — |
| 2024-05-01 | VCELVericel Corp · Stock Option (Right to Buy)A Award | — |
| 2023-06-15 | SCYXSCYNEXIS INCA Award | — |
| 2023-06-15 | SCYXSCYNEXIS INC · Stock OptionA Award | — |
| 2023-06-06 | AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award | — |
| 2023-06-06 | AKBAAkebia Therapeutics, Inc.A Award | — |
| 2023-05-03 | VCELVericel Corp · Restricted Stock UnitA Award | — |
| 2023-05-03 | VCELVericel Corp · Stock Option (right to buy)A Award | — |
| 2023-04-27 | VCELVericel CorpM Exercise/Conversion | — |
| 2023-04-27 | VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion | — |
| 2022-06-17 | SCYXSCYNEXIS INC · Stock Option (Right to Buy)A Award | — |
| 2022-06-17 | SCYXSCYNEXIS INCA Award | — |
| 2022-06-08 | AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award | — |
| 2022-06-08 | AKBAAkebia Therapeutics, Inc.A Award | — |
| 2022-06-03 | AKBAAkebia Therapeutics, Inc.S Sale | −$1,653.254 |
| 2022-05-17 | CONTRAFECT CorpOptions (Right to Buy)A Award | +$141K |
| 2022-04-29 | VCELVericel CorpS Sale | −$27.8K |
| 2022-04-27 | VCELVericel CorpM Exercise/Conversion | — |
| 2022-04-27 | VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion | — |
| 2022-04-27 | VCELVericel Corp · Restricted Stock UnitA Award | — |
| 2022-04-27 | VCELVericel Corp · Stock Option (right to buy)A Award | — |
| 2021-11-29 | VCELVericel Corp · Stock Option (right to buy)M Exercise/Conversion | — |
| 2021-11-29 | VCELVericel CorpS Sale | −$196K |
| 2021-11-29 | VCELVericel CorpM Exercise/Conversion | +$18.7K |
| 2021-10-27 | VCELVericel CorpM Exercise/Conversion | +$18.7K |
| 2021-10-27 | VCELVericel CorpS Sale | −$253K |
| 2021-10-27 | VCELVericel Corp · Stock Option (right to buy)M Exercise/Conversion | — |
| 2021-09-30 | VCELVericel Corp · Stock Option (right to buy)M Exercise/Conversion | — |
Recent filings
- 4GILMAN STEVEN C0000950170-25-091562SEC(opens sec.gov)
- 4GILMAN STEVEN C0001562180-25-004719SEC(opens sec.gov)
- 4GILMAN STEVEN C0001140361-24-043695SEC(opens sec.gov)
- 4GILMAN STEVEN C0001140361-24-042882SEC(opens sec.gov)
- 4GILMAN STEVEN C0001140361-24-041562SEC(opens sec.gov)
- 4GILMAN STEVEN C0001140361-24-040228SEC(opens sec.gov)
- 4GILMAN STEVEN C0000950170-24-076235SEC(opens sec.gov)
- 4GILMAN STEVEN C0001562180-24-004906SEC(opens sec.gov)